Shares of Aequus Pharmaceuticals Inc. (CVE:AQS – Get Free Report) hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as C$0.01 and last traded at C$0.01, with a volume of 88000 shares traded. The stock had previously closed at C$0.01.
Aequus Pharmaceuticals Trading Down 50.0 %
The firm has a market cap of C$663,150.00, a PE ratio of -0.50 and a beta of -0.02. The company has a debt-to-equity ratio of 138.88, a quick ratio of 0.46 and a current ratio of 0.07. The company has a 50 day simple moving average of C$0.01 and a two-hundred day simple moving average of C$0.01.
About Aequus Pharmaceuticals
Aequus Pharmaceuticals Inc operates as a specialty pharmaceutical company in Canada. The company markets ZIMED PF, a preservative-free bimatoprost ophthalmic solution. It also develops a range of prescription-free dry eye products under the OPTASE name; and REV-0100 for the treatment of stargardt disease.
Featured Articles
- Five stocks we like better than Aequus Pharmaceuticals
- The Risks of Owning Bonds
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- Do ETFs Pay Dividends? What You Need to Know
- Alphabet’s Officially In A Bear Market—Time To Buy?
- High Dividend REITs: Are They an Ideal Way to Diversify?
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for Aequus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aequus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
